Tag: Vaccination uptake
-
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: A Lyon, France, single-centre retrospective study
Overview The 2022 mpox outbreak prompted targeted vaccination campaigns for men who have sex with men (MSM) at risk. A large retrospective study from Lyon University Hospital, France, assessed first-dose uptake of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine among MSM attending STI and HIV clinics between January 2022 and February 2023. The study categorized…
-
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: Insights from Lyon, France
Overview and context The 2022 mpox outbreak prompted a targeted vaccination campaign for at-risk populations, notably men who have sex with men (MSM) with multiple sexual partners. A large retrospective study from Lyon University Hospital in France evaluated first-dose mpox vaccination (modified vaccinia Ankara-Bavarian Nordic) uptake among MSM and explored several determinants that influenced whether…
-
Infant RSV Immunisation in Australia: Thousands Protected, Yet Gaps Remain
Introduction: A watershed moment for RSV protection In 2025, Australia introduced free access to RSV immunisations for all infants, supported by the national RSV Mother and Infant Protection Program (RSV-MIPP). Early indicators are promising: thousands of babies have been shielded from severe RSV, and hospital admissions for RSV-related bronchiolitis and pneumonia have fallen compared with…
-
Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination Among Adults: An RCT Analysis
Overview Public health campaigns continue to seek effective ways to increase COVID-19 vaccination among adults. A recent randomized controlled trial tested two theory-informed messaging approaches—attitudinal inoculation and cognitive behavioral therapy (CBT) kernel messaging—against standard public health messaging to see which could elevate vaccine uptake or readiness. The study focused on adults in the United States…
-
Nasal Flu Spray for Kids Aims to Boost Australian Vaccination Rates Ahead of 2026
Rollout overview: Intranasal FluMist for young children A new influenza vaccine delivered as a nasal spray will be rolled out for children aged two to five in Australia ahead of the 2026 flu season. The intranasal formulation is needle-free and is touted by the Royal Australian College of General Practitioners as “as easy as it…